動物用抗感染症薬市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、製品タイプ別、投与経路別、流通経路別、地域別、競合別、2020-2030年

動物用抗感染症薬の世界市場は、2024年に83億7,000万米ドルと評価され、CAGR 6.45%で2030年には122億米ドルに達すると予測されています。

世界の動物用抗感染症薬市場は、家畜やコンパニオンアニマルの個体数が増加し続け、効果的な疾病予防・治療ソリューションへの需要が高まるにつれ、安定した成長を遂げています。抗感染症剤は、動物の健康を維持し、食品の安全性を確保し、動物由来のタンパク質の世界的な供給を支える上で重要な役割を果たしています。動物における細菌性、ウイルス性、真菌性の感染症が増加していることから、畜産とコンパニオンアニマルの両部門において、高度な抗感染症薬に対する強いニーズが生まれています。タイムリーな獣医療の重要性に対する農家やペットの飼い主の意識の高まりが、抗生物質、抗ウイルス剤、抗真菌剤、併用療法の採用をさらに加速させています。食肉、牛乳、卵の需要増に対応するための商業的畜産の拡大が疾病管理の重要性を高め、動物用抗感染症薬は現代の動物医療に不可欠な要素となっています。

市場の成長促進要因には、人獣共通感染症の発生率の上昇が含まれ、公衆衛生を守るために動物の感染症対策への関心が高まっています。獣医学研究開発への投資の増加も、長時間作用型注射剤、標的薬物送達システム、耐性問題に対処する併用療法など、抗感染症製剤の技術革新に拍車をかけています。治療コストを削減し生産性を向上させる健康管理手法に生産者や飼い主がシフトしているため、予防的ソリューションへの需要が高まっています。市場を形成する大きな動向は、抗菌剤耐性に関する世界的な懸念を反映し、プロバイオティクス、フィトジェニック、免疫賦活剤といった抗生物質の代替品への移行です。また、診断技術の絶え間ない進歩により、感染症の迅速な発見が可能になり、抗感染症の効果的な使用を補完し、精密な獣医療を支えています。

市場は、今後数年間の可能性を制限しかねない課題に直面しています。新しい動物用医薬品の開発コストが高く、規制当局の承認プロセスが厳しいため、製品の上市が遅れ、特定の地域での入手が制限されることが多いです。抗菌剤耐性をめぐる懸念は抗生物質の使用制限の厳格化につながっており、メーカーは代替品への投資を迫られる一方で、エンドユーザーにとっての値ごろ感とのバランスを取る必要があります。小規模畜産農家では、抗感染症の正しい使用法に関する認識が低いため、誤用や有効性の低下、耐性リスクの増大が生じる可能性があります。また、遠隔地や過疎地におけるサプライチェーンの制約も、重要な医薬品へのタイムリーなアクセスを制限しています。このような課題に対処するには、政府、製薬企業、動物医療サービス提供者が連携して、認知度を高め、流通網を強化し、より安全で持続可能な抗感染症ソリューションの技術革新を加速させる必要があります。このようなハードルがあるにもかかわらず、動物用抗感染症薬世界市場は、動物医療ニーズの高まり、医療慣行の進化、動物用治療薬の継続的な進歩に支えられ、拡大が見込まれています。

主な市場促進要因

家畜・家禽における感染症の発生率の上昇

主な市場課題

抗菌薬耐性（AMR）に対する懸念の高まり

主な市場動向

処方箋ベースのチャネルとデジタル販売の拡大

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の動物用抗感染症薬市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 動物の種類別（家畜、コンパニオンアニマル）
  • 製品別（抗菌剤、抗真菌剤、抗ウイルス剤、抗寄生虫剤、その他）
  • 投与経路別（経口、注射、局所）
  • 流通チャネル別（病院/クリニック薬局、薬局小売、Eコマース）
  • 企業別（2024）
  • 地域別
• 市場マップ

第6章 北米の動物用抗感染症薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の動物用抗感染症薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の動物用抗感染症薬市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の動物用抗感染症薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの動物用抗感染症薬市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 混乱：紛争、パンデミック、貿易障壁

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Zoetis Inc.
• Boehringer Ingelheim Animal Health GmbH
• Merck & Co., Inc.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Ceva Sante Animale S.A.
• Virbac S.A.
• Biogenesis Bago S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Limited

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Veterinary Anti-infectives Market was valued at USD 8.37 Billion in 2024 and is expected to reach USD 12.20 Billion by 2030 with a CAGR of 6.45%. The Global Veterinary Anti-infectives Market is experiencing steady growth as livestock and companion animal populations continue to rise, driving greater demand for effective disease prevention and treatment solutions. Anti-infectives play a critical role in maintaining animal health, ensuring food safety, and supporting the global supply of animal-based proteins. The increasing prevalence of bacterial, viral, and fungal infections in animals is creating a strong need for advanced anti-infective medicines across both livestock and companion animal sectors. Growing awareness among farmers and pet owners about the importance of timely veterinary care has further accelerated the adoption of antibiotics, antivirals, antifungals, and combination therapies. Expanding commercial livestock farming to meet the rising demand for meat, milk, and eggs has amplified the importance of disease control, positioning veterinary anti-infectives as an indispensable component of modern animal healthcare practices.

Growth drivers for the market include the rising incidence of zoonotic diseases, which has heightened the focus on controlling animal infections to safeguard public health. Increasing investments in veterinary research and development are also fueling innovation in anti-infective formulations, including long-acting injectables, targeted drug delivery systems, and combination therapies that address resistance issues. Demand for preventive solutions is gaining traction as producers and pet owners shift toward health management practices that reduce treatment costs and improve productivity. A major trend shaping the market is the transition toward antibiotic alternatives such as probiotics, phytogenics, and immunostimulants, reflecting global concerns about antimicrobial resistance. Continuous advancements in diagnostic technologies are also enabling faster detection of infections, which complements the effective use of anti-infectives and supports precision veterinary medicine.

The market faces challenges that could restrict its potential in the coming years. High development costs for new veterinary medicines, coupled with stringent regulatory approval processes, often delay product launches and limit accessibility in certain regions. Concerns around antimicrobial resistance are leading to stricter restrictions on antibiotic usage, pressuring manufacturers to invest in alternatives while balancing affordability for end users. Limited awareness among small-scale livestock farmers about the correct use of anti-infectives can result in misuse, reduced efficacy, and increased resistance risks. Supply chain limitations in remote or underdeveloped areas also restrict timely access to critical medicines. Addressing these challenges requires coordinated efforts between governments, pharmaceutical companies, and veterinary service providers to enhance awareness, strengthen distribution networks, and accelerate innovation in safer, sustainable anti-infective solutions. Despite these hurdles, the Global Veterinary Anti-infectives Market is expected to expand, supported by rising animal health needs, evolving healthcare practices, and ongoing advancements in veterinary therapeutics.

Key Market Drivers

Rising Incidence of Infectious Diseases in Livestock and Poultry

The rising incidence of infectious diseases in livestock and poultry is a significant driver of the Global Veterinary Anti-infectives Market. In the United States, the USDA reported processing over 9.4 billion broiler chickens and 218 million turkeys in 2023. This large-scale production increases the risk of disease outbreaks, necessitating effective anti-infective solutions to maintain animal health and productivity. Similarly, India, with the world's highest livestock population, including 300 million cattle and buffaloes and 851 million poultry, faces challenges in managing diseases among its vast animal population. The prevalence of diseases such as Foot and Mouth Disease and Lumpy Skin Disease in these regions underscores the need for robust veterinary anti-infective measures.

In China, the Ministry of Agriculture and Rural Affairs has been proactive in enhancing animal health surveillance and disease control programs to address the growing concerns of infectious diseases in livestock and poultry. The government's efforts to strengthen veterinary infrastructure and promote disease prevention strategies have contributed to the increased demand for veterinary anti-infectives. These initiatives aim to mitigate the impact of infectious diseases on animal health and ensure food security. The escalating incidence of infectious diseases in livestock and poultry across these regions highlights the critical need for effective veterinary anti-infectives to safeguard animal health and support the growth of the global veterinary anti-infectives market.

Key Market Challenges

Rising Concerns Over Antimicrobial Resistance (AMR)

Rising concerns over antimicrobial resistance (AMR) represent one of the most significant challenges for the Global Veterinary Anti-infectives Market, as the misuse and overuse of antibiotics in livestock and companion animals contribute to the development of drug-resistant pathogens. AMR poses serious threats not only to animal health but also to human health due to the potential transfer of resistant bacteria through the food chain, direct contact, or environmental contamination. Regulatory authorities worldwide are increasingly implementing stricter guidelines to limit antibiotic use in animals, including restrictions on growth-promoting antibiotics and tighter controls on prophylactic administration. These regulations create pressure on manufacturers and veterinarians to adopt alternative approaches to disease management, such as vaccines, immunostimulants, probiotics, and other non-antibiotic therapies, which may not always be as widely available or cost-effective as traditional anti-infectives.

The growing awareness of AMR among consumers, farmers, and healthcare professionals has intensified demand for responsible and judicious use of veterinary medicines. Pharmaceutical companies face the challenge of balancing the development of effective anti-infectives with compliance to evolving global standards while ensuring affordability for farmers, particularly in emerging markets where cost sensitivity is high. Research and development efforts to create next-generation therapies that are effective yet less prone to resistance are resource-intensive, requiring significant time and financial investment. Inadequate farmer education and poor adherence to dosing protocols can exacerbate resistance issues, further complicating disease management. The AMR challenge is reshaping treatment strategies and driving innovation in veterinary medicine, but it also imposes significant operational, regulatory, and economic pressures on the veterinary anti-infectives market, making it a critical hurdle for sustained growth and adoption.

Key Market Trends

Expansion of Prescription-Based Channels and Digital Sales

A key trend in the Global Veterinary Anti-infectives Market is the expansion of prescription-based channels and digital sales, which is reshaping how veterinary medicines are accessed and distributed. Increasing regulatory oversight on antimicrobial usage, aimed at combating antimicrobial resistance, has led many countries to restrict the availability of certain anti-infective drugs over the counter, prompting a shift toward prescription-only access. This transition ensures more controlled and responsible usage of antibiotics, antivirals, and antifungal medications, while improving adherence to dosage guidelines and reducing the risk of resistance development. Prescription-based channels also allow veterinarians to play a more active role in disease management, guiding producers and pet owners on the appropriate choice of therapy and monitoring treatment outcomes.

Simultaneously, digital sales platforms and e-commerce solutions are expanding the reach of veterinary anti-infectives to both urban and rural markets. Online pharmacies and veterinary supply platforms provide convenient access to a broad portfolio of medicines, particularly for farmers managing large herds or flocks where timely procurement is essential. Integration of digital tools with prescription channels enables better tracking of drug usage, inventory management, and compliance with veterinary guidelines. Telemedicine and virtual consultation services are also gaining traction, allowing veterinarians to diagnose, prescribe, and monitor treatments remotely, which is especially valuable in regions with limited veterinary infrastructure. The combination of stricter prescription regulations and the convenience of digital sales channels is transforming the market landscape, enhancing accessibility, supporting antibiotic stewardship programs, and encouraging data-driven decision-making in veterinary healthcare. This trend is expected to continue shaping the adoption and distribution of anti-infectives across livestock and companion animal segments globally.

Key Market Players

• Zoetis Inc.
• Boehringer Ingelheim Animal Health GmbH
• Merck & Co., Inc.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Ceva Sante Animale S.A.
• Virbac S.A.
• Biogenesis Bago S.A.
• Vetoquinol S.A.
• Norbrook Laboratories Limited

Report Scope:

In this report, the Global Veterinary Anti-infectives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Anti-infectives Market, By Animal Type:

• Livestock Animal
• Companion Animal

Veterinary Anti-infectives Market, By Product:

• Antimicrobial
• Antifungals
• Antivirals
• Antiparasitic
• Others

Veterinary Anti-infectives Market, By Route of Administration:

• Oral
• Injectable
• Topical

Veterinary Anti-infectives Market, By Distribution Channel:

• Hospital/ Clinic Pharmacy
• Retail Pharmacies
• E-commerce

Veterinary Anti-infectives Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Anti-infectives Market.

Available Customizations:

Global Veterinary Anti-infectives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary Anti-infectives Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Livestock Animal, Companion Animal)
  • 5.2.2. By Product (Antimicrobial, Antifungals, Antivirals, Antiparasitic, Others)
  • 5.2.3. By Route of Administration (Oral, Injectable, Topical)
  • 5.2.4. By Distribution Channel (Hospital/ Clinic Pharmacy, Retail Pharmacies, E-commerce)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Veterinary Anti-infectives Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Route of Administration
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Veterinary Anti-infectives Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Veterinary Anti-infectives Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Veterinary Anti-infectives Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By Distribution Channel

7. Europe Veterinary Anti-infectives Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Route of Administration
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Veterinary Anti-infectives Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Veterinary Anti-infectives Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Veterinary Anti-infectives Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Veterinary Anti-infectives Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Veterinary Anti-infectives Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Veterinary Anti-infectives Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Route of Administration
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Veterinary Anti-infectives Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Veterinary Anti-infectives Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Veterinary Anti-infectives Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Veterinary Anti-infectives Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Route of Administration
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Veterinary Anti-infectives Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Route of Administration
      • 8.3.5.2.4. By Distribution Channel

9. South America Veterinary Anti-infectives Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Route of Administration
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Veterinary Anti-infectives Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Veterinary Anti-infectives Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Veterinary Anti-infectives Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Veterinary Anti-infectives Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Route of Administration
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Veterinary Anti-infectives Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Veterinary Anti-infectives Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Veterinary Anti-infectives Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zoetis Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Boehringer Ingelheim Animal Health GmbH
• 15.3. Merck & Co., Inc.
• 15.4. Dechra Pharmaceuticals PLC
• 15.5. Elanco Animal Health Incorporated
• 15.6. Ceva Sante Animale S.A.
• 15.7. Virbac S.A.
• 15.8. Biogenesis Bago S.A.
• 15.9. Vetoquinol S.A.
• 15.10. Norbrook Laboratories Limited

16. Strategic Recommendations

17. About Us & Disclaimer